Gene: TMEM176B
Official Full Name: transmembrane protein 176Bprovided by HGNC
Gene Summary: Predicted to be involved in negative regulation of dendritic cell differentiation. Predicted to be located in nuclear membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06095 | TMEM176B Knockout cell line (HeLa) | Human | TMEM176B | 1:3~1:6 | Negative | Online Inquiry |
KO06096 | TMEM176B Knockout cell line (HEK293) | Human | TMEM176B | 1:3~1:6 | Negative | Online Inquiry |
TMEM176B Gene Knockout Cell Lines are engineered cellular models that specifically lack the expression of the TMEM176B gene, which encodes for a transmembrane protein involved in the regulation of immune responses. By employing CRISPR/Cas9 technology, these cell lines facilitate precise genomic editing, allowing researchers to assess the functional consequences of TMEM176B deficiency. The knockout of this gene alters cellular physiology, providing a platform for investigations into its role in processes such as inflammation, antigen presentation, and T cell activation.
The key mechanism of action in these cell lines lies in their ability to mimic disease states or investigate biological pathways by directly observing the absence of the TMEM176B protein. This is achieved through a targeted deletion that enables researchers to delineate the gene's influence on cellular behavior and interactions with the immune system. By utilizing these cell lines, scientists can explore the implications of TMEM176B in autoimmune diseases, cancer immunology, and therapeutic responses.
The scientific importance of TMEM176B Gene Knockout Cell Lines is underscored by their application in both bench research and translational studies. They serve as invaluable tools for elucidating disease mechanisms, testing the efficacy of new therapeutic strategies, and evaluating the safety profiles of potential drugs. Compared to conventional knockdown approaches using RNA interference, these knockout cell lines provide a more permanent and precise alteration, resulting in more robust data reproducibility.
For researchers and clinicians, the unique selling point of the TMEM176B Gene Knockout Cell Lines lies in their specificity and high-fidelity gene editing. This allows for a deeper understanding of the biological role of TMEM176B, setting the stage for novel insights into treatment avenues for immune-related disorders. The ability to generate reproducible and consistent results within a defined experimental framework enhances experimental rigor and translates into higher-impact findings.
Our company prides itself on its expertise in genetic engineering and cell line development, offering a range of innovative solutions tailored for the advanced research community. By providing high-quality TMEM176B Gene Knockout Cell Lines, we empower researchers with the tools necessary to unravel the complexities of cellular biology and enhance therapeutic discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.